27-28 September, 2018

Boston, USA



Exhibition Partner

Saretius is a UK-based company offering preclinical experimental services required by the drug discovery process, in a highly integrated fashion. Therapeutic areas covered by Saretius are pain, inflammation, metabolic and CNS disorders as well as cardiovascular safety. Saretius offers a unique service by integrating efficacy testing, therapeutic index, pharmacokinetics (PK) and pharmacodynamics (PD). This highly integrated approach helps to accelerate the drug discovery process and reduce risk in drug development by identifying PK/PD relationships.